Article
NGS-Based Mutation Profiling and PD-L1 Expression in NSCLC Patients: A Single-Centre Prospective Analysis.
Turk patoloji dergisi - 1 Jan 2026
Sayyada Anab, Gautam Dheeraj, Sharma Rashi, Bhat Apeksha, Wadhwa Jyoti, Arya Mamta
Abstract excerpt
OBJECTIVE: Non-small cell lung cancer (NSCLC) is a molecularly heterogeneous disease in which both actionable mutations and PD-L1 expression influence therapeutic decisions. This study aimed to evaluate the molecular profile of NSCLC using next-generation sequencing (NGS) and analyse the association of PD-L1 expression with key genetic alterations. MATERIAL AND METHODS: A retrospective analysis was conducted on...
Read the complete abstract on PubMedTopics
- Humans
- Carcinoma, Non-Small-Cell Lung
- B7-H1 Antigen
- Lung Neoplasms
- Female
- Male
- Middle Aged
